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Background: Ablative laser therapy with carbon dioxide is effective for acne scars; however, the long
downtime limits its use, especially in types III and IV skin. The fractional ablative 10,600-nm carbon
dioxide laser system reportedly maximizes efﬁcacy and minimizes side effects. The goal of this study was
to evaluate the efﬁcacy and safety of an ablative 10,600-nm carbon dioxide fractional laser system in
a single treatment session on atrophic acne scars in Asian patients.
Methods: Twenty-ﬁve patients with atrophic acne scars were enrolled. The laser ﬂuences were delivered
using the Deep FX mode. Comparative photographs were taken with VISIA complexion analysis. Physi-
cian evaluation and patient satisfaction were graded on a four-point scale.
Results: At follow-up 1 month after treatment, four patients showed 51e75% improvement, 16 had 26
e50% improvement, and ﬁve had minimal or no improvement. At 3 months, two patients had excellent
results (76% and 100% improvement). Postinﬂammatory hyperpigmentation was present in six of the 25
(24%) patients; by 3 months’ follow-up, this had faded in ﬁve of six cases.
Conclusion: A single treatment with the carbon dioxide fractional laser system is effective for acne scars
in Asian patients, with minimal and acceptable side effects.
Copyright  2012, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Atrophic acne scars cause signiﬁcant disﬁgurement, especially on
the face.1 Laser resurfacing is an effective treatment that is easier to
use than other treatment modalities such as chemical peeling,
surgical excision, punch grafting, dermabrasion, and dermal ﬁllers.2
Ablative laser therapies with carbon dioxide (CO2) or erbium-
doped yttrium aluminum garnet (Er:YAG) lasers are well-
recognized for the treatment of acne scars and skin rejuvenation.3,4
Fractional photothermolysis systems (mostly using 1550-nm
erbium-doped lasers) in the treatment of acne scars have been
reported,5e8 although CO2 fractional laser treatment has rarely been
compared with traditional ablative CO2 laser resurfacing in a head-
to-head study. One of the disadvantages of traditional laser
ablation is the long downtime due to prolonged erythema and
postinﬂammatory hyperpigmentation (PIH), especially in darker-y, Mackay Memorial Hospital,
Taiwan.
iwanese Dermatological Associatioskinned individuals.9,10 Fractional photothermolysis with an abla-
tive 10,600-nm CO2 laser reportedly has more transient, mild-to-
moderate post-treatment side effects.11e16 Recovery and the effects
of such treatment among Asian patients have been reported to be
limited.11,13,16
In this prospective study, a CO2 fractional laser system with
moderate treatment settings was used in a single treatment session
for atrophic acne scars in Asian patients. Speciﬁc complexion
analysis photography was used to assess the outcome in an attempt
to more clearly deﬁne the efﬁcacy and safety of this procedure in
these patients.
Methods
Patients
Twenty-ﬁve Asian patients (15 men and 6 women; mean age 30.4
years, range 19e39 years) with mild-to-moderate acne scars (skin
types III and IV) were enrolled. The exclusion criteria included
pregnancy, lactation, immunosuppression, isotretinoin use, and/or
a history of keloid scarring.n. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1 Degree of improvement evaluated by physicians at 1 month and 3 months
post-treatment.
Degree of improvement 1 month 3 months
Grade 4 (76e100%) 0 (0%) 2 (12%)
Grade 3 (51e75%) 4 (16%) 5 (29%)
Grade 2 (26e50%) 16 (64%) 8 (47%)
Grade 1 (0e25%) 5 (20%) 2 (12%)
Total number of patients 25 17
Eight patients did not return for follow-up at 3 months after the treatment.
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or used any prophylactic antiviral medication. No other ablative
resurfacing or ﬁller injections had been performed in the 6 months
preceding this study.
Atrophic scars were classiﬁed into four types, with most
patients having three or four types: shallow atrophic scars in 14
cases, (56%), boxcar scars in 17 (68%), rolling scars in 10 cases (40%),
and ice-pick scars in six cases (24%). The treatment area included
the cheeks in 24 patients and the nose only in one patient.
Treatment
The areas to be treated were ﬁrst cleansed with a mild cleanser and
70% alcohol. Topical anesthesia with 2.5% lidocaine and 2.5% pri-
locaine cream (EMLA) was applied 60 minutes before initiating
treatment. A single session of CO2 fractional photothermolysis
using a 10,600-nm UltraPulse (Encore laser; Lumenis Inc., Santa
Clara, CA, USA)was delivered using the Deep FXmodewith settings
of 12.5e15 mJ, density 2e3, and frequency 300 Hz.
Immediately after treatment, ice packs were applied for at least
10 minutes to relieve burning. An occlusive dressing (Duoderm,
ConvaTec, USA) was applied to the treated areas and was changed
daily for the ﬁrst 2 days. After the 2nd day, a moisturizer (Phase O
total care; Phasilab, France) was applied liberally, and a broad-
spectrum sunscreen was recommended for daily use to avoid
overexposure to sunlight.
Evaluation
Digital photographs were taken and analyzed using VISIA
Complexion Analysis (Canﬁeld Scientiﬁc, Inc., Voorhecs, NJ, USA) to
establish the numbers of pores (including follicular openings and
atrophic scars) and skin texture scores at baseline, 1 week, 1 month,
and 3 months after treatment. The region of interest for each image
was deﬁned in the same way for all images using predeﬁned land-
marks on the face andwas analyzed using customized software that
automatically identiﬁed and quantiﬁed features such as texture,
score, wrinkles, pigment, and redness. The details for each skin
featurewere indexed,which allowed comparison between the same
patient at different points in time as well as between patients. VISIA
identiﬁed large follicular openings and atrophic scars as pores and
recognized peaks and valleys on the skin surface to analyze skin
texture, thus reﬂecting skin smoothness. VISIA scoreswere available
for all but the patient whose treatment was limited to the nose.
In addition to VISIA analysis, two dermatologists independently
compared the digital photos for clinical evaluation of the acne scars.
A four-point scale was used: Grade 1, <25% improvement; Grade 2,
26e50% improvement; Grade 3, 51e75% improvement; and Grade
4, >75% improvement. Patients used a similar four-point scale to
indicate their degree of satisfaction with the results. Side effects of
treatment, including crusting or scaling, erythema, pigmentation,
acne, or pruritus, were reported on follow-up.
Statistical analysis
Variables measured at different time points were compared using
the Wilcoxon signed-rank test. A value p < 0.05 was considered
statistically signiﬁcant. SAS 9.0 software (SAS Institute Inc., Cary,
NC, USA) was used to perform the statistical analysis.
Results
On clinical assessment by the physicians, the majority of patients
scored Grade 1e2 improvement at 1 month, although none ach-
ieved Grade 4. The mean grade of improvement at 1 month overbaseline was 1.96 (Table 1, Figure 1). After 3 months, the mean
improvement in grade over baseline was 2.41 (Table 1, Figure 2),
although eight patients did not return for follow-up at that point.
Age, sex, and scar type did not signiﬁcantly affect the improvement
in grade.
The patients tended to see less improvement than the physi-
cians. Again, none reported Grade 4 results at 1 month, but two did
at 3 months. At that point, however, sevenwere still reporting only
Grade 1 results (Table 2). Of the eight patients who did not come
back for follow-up 3months after treatment, six could be contacted
by telephone (all of whomhad reported Grade 1 for their scarring at
the 1-month follow-up) and stated that the results remained the
same at 3 months. These results are included in Table 2.
Compared to baseline, the 1-month VISIA scores for skin texture
and pores were signiﬁcantly decreased; however, the residual
redness score was signiﬁcantly increased. Again compared to
baseline, the 3-month scores revealed no signiﬁcant differences,
with the exception of a signiﬁcant increase in the left pore score. No
signiﬁcant differences were found in wrinkle, pigment, and
porphyria scores (Table 3).
Nine patients had erythema at 1 month, seven showing Grade 1,
and twoGrade 2, erythema. Three of these patients still had Grade 1
erythema at 3 months, a statistically signiﬁcant improvement
overall (p¼ 0.031). Six patients had Grade 1 PIH at 1month, but this
had almost faded in all except one case at 3 months. Pruritus was
present in three patients at 1 month; they reported that this
gradually subsided over the next 2 months, although they still had
dry scaly surfaces over the treatment areas at the ﬁnal follow-up.
Patients graded their skin texture as worse at 3 months post-
treatment than at 1 month post-treatment (p ¼ 0.039). Eight
patients (32%) had higher skin texture grades at 3 months than at 1
month. Three patients had a ﬂare-up of acne 1 week after
treatment.
Discussion
With one treatment of this CO2 fractional system, there was an
obvious improvement in 41% (7/17) of patients at 3 months’ follow-
up. Side effects were minimal and had mostly resolved by 3
months, and no patient suffered from obvious side effects.
However, two patients still had minor or no improvement at 3
months. This may have resulted from individual variability.
According to a recent study, the treatment appears to be more
effective in younger patients with thin skin. 17 However, no
predictive factors could be identiﬁed before the treatment. These
individuals might have needed higher treatment settings. In a small
study comparing the efﬁcacy and safety of a low-ﬂuence, high-
density CO2 fractional system with those of high-ﬂuence, low-
density treatment for acne scars, the clinical results seemed to be
more pronounced in the latter group.18
Fractional photothermolysis is an effective modality for the
treatment of a variety of conditions, including photoaging and
acne scarring, although the results have all been based on multiple
treatments.6,10,11,19 Previous reports on CO2 ablative resurfacing
have involved at least three sessions.12,14,16,20 Cho et al studied the
Figure 1 Atrophic and boxcar acne scars in a 24-year-old man before and after one session of fractional resurfacing using Deep FX therapy, 15 mJ with a density of 10%, showing
moderate improvement; (A) right cheek, baseline; (B) right cheek, 1 month; (C) left cheek, baseline; (D) left cheek, 1 month.
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scars and conducted a split-face study comparing non-ablative
1550 nm erbium glass and ablative 10,600-nm CO2 fractional
photothermolysis treatments.11,13 Their small pilot study demon-
strated the efﬁcacy and safety of single-session acne scar treatment,Figure 2 Boxcar and ice pick acne scars in a 28-year-old man before and after one session
moderate improvement: (A) right cheek, baseline; (B) right cheek, 3 months; (C) left cheekand the CO2 fractional laser systemwas proven more effective than
the fractional photothermolysis system.
However, in Cho et al’s study, two treatment CO2 fractional laser
systemmodes (Deep FX and Active FX)were combined.11 In another
report by the same group, they indicated that adding one pass ofof fractional resurfacing using Deep FX therapy, 15 mJ with a density of 10%, showing
, baseline; (D) left cheek, 3 months.
Table 2 Degree of improvement evaluated by patients at 1 month and 3 months
post-treatment.
Degree of improvement 1 month 3 months
Grade 4 (76e100%) 0 (0%) 2 (9%)
Grade 3 (51e75%) 3 (14%) 2 (9%)
Grade 2 (26e50%) 5 (24%) 6 (26%)
Grade 1 (0e25%) 17 (62%) 13 (56%)a
Total number of patients 25 23
Eight patients did not return for follow-up 3 months after treatment.
a Six patients could be contacted by telephone (all of whom had been Grade 1 at 1
month follow-up) and stated that the results remained the same at 3 months; this
information has been included in the table.
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prolonged thepost-treatmentdowntime from2days to7days.13 The
prolonged recovery period therefore made this treatment protocol
less acceptable than the fractional photothermolysis system. In
contrast, we chose to use only one Deep FX pass with a spot size of
0.12 mm, which was more comparable to the healing process of the
fractional photothermolysis system alone.
In our study, further improvement was reported subjectively
(i.e., by patients and physicians) at 3 months compared to 1 month
post-treatment. The objective evaluation by VISIA showed signiﬁ-
cant improvement in skin texture and pore number at 1 month but
only minimal improvement at 3 months. In several patients with
increased skin texture and pore scores, dry scaly surfaces were
observed at 3 months, which may account for the worsening of the
skin texture grade reported by patients at 3 months post-
treatment. The dry, irregular surface may interfere with the VISIA
evaluation, resulting in higher scores. Using an emollient contain-
ing glycyrrhetinic acid silico-lactic complex for 2 days immediately
following treatment effectively reduced the incidence of dry skin,
which was a major complaint post-treatment.
In previous studies with three sessions of fractional CO2 resur-
facing, the improvement in skin texture and atrophy scars was
greater at 3 months than at 1 month. However, the subjective
improvement reported by these patients in the overall appearance
of their acne scarring was lower at 3 months (2.0) than at 1 month
(2.22).12 The less obvious improvement by VISIA evaluation at 3
months in our study may be in part due to the use of only one
treatment session, which resulted in a less sustainable effect than
three sessions.14
The average level of improvement at 3 months (2.41) observed
for our patients was similar to the ﬁndings of other studies (rangeTable 3 Summary for the changes of the evaluated scores measured at 1 month and
3 months post-treatment.
Changes from baseline 1 montha (n ¼ 24) 3 montha (n ¼ 16) p
Texture score Right 144.8  133.1y 86.4  258.0 0.003*
Left 192.6  251.6y 165.1  328.3 0.003*
Pore score Right 56.4  70.3y 14.5  77.0 0.001*
Left 62.9  91.0y 58.7  100.6y 0.002*
Wrinkle score Right 0.9  6.8 0.9  6.7 0.922
Left 0.1  4.2 1.3  5.3 0.029*
Pigment score Right 4.8  12.4 0.3  12.2 0.096
Left 3.2  14.3 2.3  14.3 0.570
Redness score Right 26.3  51.8y 14.4  49.6 0.004*
Left 19.9  39.9y 10.4  48.9 0.002*
Porphyria score Right 96.4  218.3 10.1  183.8 0.464
Left 55.2  265.8 10.8  199.9 0.520
Data are presented as mean  SD.
a One patient did not have a VISIA score at 1 month, and nine patients had no
VISIA score (8 did not return for follow-up) at 3 months, after treatment
* Signiﬁcant difference in the corresponding data measured at 1 month and 3
months post-treatment
y Statistical signiﬁcance was found compared with baseline.2.4e2.5).12,14We also found a slight decrease in porphyria score at 1
month (96.4, 55.2) but not at 3 months. Most patients experi-
enced better control of their acne, with only three having an acne
ﬂare between 1 week and 1 month. There is currently still no
consensus on the interval between treatment sessions. Based on
our ﬁndings, if more than one treatment is to be given in order to
achieve better long-term results, the interval between sessions
could be 3 months. Shorter intervals may be adopted by non-
responders.
The low incidence of PIH in our Asian patients also supports this
recommendation. Although six (24%) of the 25 subjects displayed
PIH at 1 month, it had faded by 3 months. Other studies of Asian
patients have reported percentages of PIH at 3 months of between
0% and 13%.5,11,19 In one Asian study, patients reported an alarm-
ingly high rate of PIH (92.3%) soon after treatment, but the condi-
tion resolved completely in all cases in an average of 5 weeks.16 We
also observed this quick resolution. A lower incidence of PIH is
reported in Caucasians following three treatments with a CO2
fractional laser system. In one study, two of 15 patients had trace-
to-mild PIH at the 3-month follow-up.12 A similar study showed
a 12% rate of PIH,14 comparable to the 10e12% incidence following
mid-infrared fractional photothermolysis.21
The incidence of PIH may be more related to the density than
the energy of the laser treatment.22 Based upon the low incidence
of PIH in this study, we consider a density of 10e15% to be safe. At
this density, however, either higher energy or a greater number of
treatments may be required to achieve the desired cosmetic effect
in low- or nonresponders.
We hope that by sharing the results of our treatment experi-
ences, future studies can be conducted to deﬁne the range of safe
and effective parameters in the treatment of atrophic acne scars in
Asian patients.
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